NHS bill for US drugs 'could soar under post-Brexit trade deal' The price the NHS pays for US medicines could soar under a trade deal with the United States after the UK leaves the European Union, according to an investigation.
Despite Boris Johnson’s assertion that the NHS is not on the table, sources with knowledge of the initial trade discussions between the two countries question whether the Prime Minister is able to keep to that promise. In fact “drug pricing” has been discussed in six initial meetings between trade officials from the two countries and secret meetings between US drugs firms and British civil servants where medicine “price caps” have been talked about, according to Dispatches. iNews
See also:
Despite Boris Johnson’s assertion that the NHS is not on the table, sources with knowledge of the initial trade discussions between the two countries question whether the Prime Minister is able to keep to that promise. In fact “drug pricing” has been discussed in six initial meetings between trade officials from the two countries and secret meetings between US drugs firms and British civil servants where medicine “price caps” have been talked about, according to Dispatches. iNews
See also:
- Trump's plan for the NHS Channel 4 Dispatches
No comments:
Post a Comment